News Story: Full Text
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

 

Curis, Roche drug combats children`s brain tumors (Medulloblastoma)


Posted on: 06/05/2010

Curis, Roche drug combats children's brain tumors

Sat Jun 5, 2010 9:00am EDT

 


 

   

 
 

 

* One patient on the drug for more than a year

STOCKS  |  GLOBAL MARKETS  |  HEALTHCARE

* Hedgehog pathway at play in 20 pct of medulloblastomas

June 5 (Reuters) - An experimental drug being developed by Curis Inc (CRIS.O) and Roche Holding AG (ROG.VX) showed promising results in a small, early-stage trial involving children with medulloblastoma, the most common type of malignant brain tumor in children.

The drug, GDC-0449, is part of a promising new class of drugs that block the Hedgehog signaling pathway, which involves several proteins that play a role in cell growth.

The Phase 1 trial results, presented here at a meeting of the American Society of Clinical Oncology, showed that 12 of 13 children with recurrent or drug-resistant medulloblastoma have tolerated the drug well without significant side effects, with one patient remaining on the drug for more than a year without disease progression.

The hedgehog pathway has been shown to be responsible for 20 percent of medulloblastomas, as well as other cancers, ASCO said in a statement.

"Some patients have remained on this trial for extended periods of time and our early results are positive and encouraging," Dr. Amar Gajjar, director of neuro-oncology at St. Jude Children's Research Hospital in Memphis, Tennessee and the trial's lead investigator, said in a statement.

Previous early-stage studies have suggested that GDC-0449 may also be effective against basal cell carcinoma in adults and there is currently a Phase II trial being conducted for adults with recurrent medulloblastoma.

Curis and Roche will also be presenting safety data at ASCO from a Phase 2 trial of GDC-0449 in patients with colorectal cancer. (Reporting by Deena Beasley; editing by Andre Grenon)

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740